In a post hoc analysis of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study, insulin and vascular complications (macrovascular disease in men and microvascular disease in women) were independently associated with fragility fractures, even when baseline glycemic control and T2DM duration were accounted for [19]. The gene discussed is INS; the disease is diabetes mellitus.